Brief: HeartSciences Files FDA 510(k) for MyoVista WaveCG Device
15/12/2025 15:17
Dec 15 (Reuters) - HeartSciences Inc HSCS.O: HEARTSCIENCES ANNOUNCES FDA 510(K) SUBMISSION FOR MYOVISTA® WAVECG™ DEVICE Source text: ID:nGNX6CxwWG Further company coverage: HSCS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HeartSciences
See all newsBrief: Heartsciences Files Definitive Proxy Statement For Proposed Business Combination With Fortitude Mining
Brief: Fortitude Provides Second Quarter 2026 Financial And Operating Highlights
Brief: Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration
Brief: Heartsciences - Files Preliminary Proxy For Business Combination With Fortitude Mining Holdings
Brief: Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights™